Separating transrepression and transactivation: A distressing divorce for the glucocorticoid receptor?

Molecular Pharmacology

Volumn 72, Issue 4, 2007, Pages 799-809

  Newton, Robert ^a   Holden, Neil S ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; BRADYKININ B1 RECEPTOR; BRADYKININ B2 RECEPTOR; CCAAT ENHANCER BINDING PROTEIN; CYCLIN D3; CYCLOOXYGENASE 2; DACTINOMYCIN; DEXAMETHASONE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN D; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 11; INTERLEUKIN 4 RECEPTOR ALPHA; INTERLEUKIN 6; INTERLEUKIN 8; MIFEPRISTONE; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; RNA POLYMERASE II; RU 24858; STAT1 PROTEIN; STAT3 PROTEIN; STAT5 PROTEIN; TATA BINDING PROTEIN; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; CONTROLLED STUDY; DNA BINDING MOTIF; DNA RESPONSIVE ELEMENT; DRUG BINDING SITE; DRUG DNA BINDING; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; INFLAMMATION; LUNG ALVEOLUS CELL TYPE 2; LUNG FIBROBLAST; LYMPHOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RAT; RNA STABILITY; SHORT SURVEY; SMOOTH MUSCLE FIBER; TATA BOX; TRANSACTIVATION; TRANSCRIPTION REGULATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; GLUCOCORTICOIDS; HUMANS; LIGANDS; RECEPTORS, GLUCOCORTICOID; REPRESSOR PROTEINS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS;

EID: 34748920671     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.107.038794     Document Type: Short Survey

References (175)

1. Abbinante-Nissen JM, Simpson LG, and Leikauf GD (1995) Corticosteroids increase secretory leukocyte protease inhibitor transcript levels in airway epithelial cells. Am J Physiol 268:L601-L606.
2. Abraham SM, Lawrence T, Kleiman A, Warden P, Medghalchi M, Tuckermann J, Saklatvala J, and Clark AR (2006) Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1. J Exp Med 203:1883-1889.
3. Adams M, Meijer OC, Wang J, Bhargava A, and Pearce D (2003) Homodimerization of the glucocorticoid receptor is not essential for response element binding: activation of the phenylethanolamine N-methyltransferase gene by dimerizationdefective mutants. Mol Endocrinol 17:2583-2592.
4. Adcock IM, Ito K, and Barnes PJ (2004) Glucocorticoids: effects on gene transcription. Proc Am Thorac Soc 1:247-254.
5. Aittomäki S, Pesu M, Groner B, Janne OA, Palvimo JJ, and Silvennoinen O (2000) Cooperation among stat1, glucocorticoid receptor, and PU.1 in transcriptional activation of the high-affinity Fc gamma receptor I in monocytes. J Immunol 164:5689-5697.
6. Auphan N, DiDonato JA, Rosette C, Helmberg A, and Karin M (1995) Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270:286-290.
7. Barker M, Clackers M, Copley R, Demaine DA, Humphreys D, Inglis GG, Johnston MJ, Jones HT, Haase MV, House D, et al. (2006) Dissociated nonsteroidal glucocorticoid receptor modulators; discovery of the agonist trigger in a tetrahydronaphthalene-benzoxazine series. J Med Chem 49:4216-4231.
8. Barnes PJ (2006) How corticosteroids control inflammation: quintiles prize lecture 2005. Br J Pharmacol 148:245-254.
9. Belvisi MG, Wicks SL, Battram CH, Bottoms SE, Redford JE, Woodman P, Brown TJ, Webber SE, and Foster ML (2001) Therapeutic benefit of a dissociated glucocorticoid and the relevance of in vitro separation of transrepression from transactivation activity. J Immunol 166:1975-1982.
10. Bergmann MW, Staples KJ, Smith SJ, Barnes PJ, and Newton R (2004) Glucocorticoid inhibition of granulocyte macrophage-colony-stimulating factor from T cells is independent of control by nuclear factor-kappaB and conserved lymphokine element 0. Am J Respir Cell Mol Biol 30:555-563.
11. Berrebi D, Bruscoli S, Cohen N, Foussat A, Migliorati G, Bouchet-Delbos L, Maillot MC, Portier A, Couderc J, Galanaud P, et al. (2003) Synthesis of glucocorticoid-induced leucine zipper (GILZ) by macrophages: an anti-inflammatory and immunosuppressive mechanism shared by glucocorticoids and IL-10. Blood 101:729-738.
12. Bilodeau S, Vallette-Kasic S, Gauthier Y, Figarella-Branger D, Brue T, Berthelet F, Lacroix A, Batista D, Stratakis C, Hanson J, et al. (2006) Role of Brg1 and HDAC2 in GR trans-repression of the pituitary POMC gene and misexpression in Cushing disease. Genes Dev 20:2871-2886.
13. Bladh LG, Liden J, Dahlman-Wright K, Reimers M, Nilsson S, and Okret S (2005) Identification of endogenous glucocorticoid repressed genes differentially regulated by a glucocorticoid receptor mutant able to separate between nuclear factor-kappaB and activator protein-1 repression. Mol Pharmacol 67:815-826.
14. Bledsoe RK, Montana VG, Stanley TB, Delves CJ, Apolito CJ, McKee DD, Consler TG, Parks DJ, Stewart EL, Willson TM, et al. (2002) Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition. Cell 110:93-105.
15. Brostjan C, Anrather J, Csizmadia V, Natarajan G, and Winkler H (1997) Glucocorticoids inhibit E-selectin expression by targeting NF-kappaB and not ATF/c-Jun. J Immunol 158:3836-3844.
16. Brostjan C, Anrather J, Csizmadia V, Stroka D, Soares M, Bach FH, and Winkler H (1996) Glucocorticoid-mediated repression of NFκB activity in endothelial cells does not involve induction of IκBα synthesis. J Biol Chem 271:19612-19616.
17. Caldenhoven E, Liden J, Wissink S, van de SA, Raaijmakers J, Koenderman L, Okret S, Gustafsson JA, and van der Saag PT (1995) Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids. Mol Endocrinol 9:401-412.
18. Catley MC, Sukkar MB, Chung KF, Jaffee B, Liao SM, Coyle AJ, Haddad e, Barnes PJ, and Newton R (2006) Validation of the anti-inflammatory properties of smallmolecule IB kinase (IKK)-2 inhibitors by comparison with adenoviral-mediated delivery of dominant-negative IKK1 and IKK2 in human airways smooth muscle. Mol Pharmacol 70:697-705.
19. Cella N, Groner B, and Hynes NE (1998) Characterization of Stat5a and Stat5b homodimers and heterodimers and their association with the glucocortiocoid receptor in mammary cells. Mol Cell Biol 18:1783-1792.
20. Chandran UR, Warren BS, Baumann CT, Hager GL, and DeFranco DB (1999) The glucocorticoid receptor is tethered to DNA-bound Oct-1 at the mouse gonadotropinreleasing hormone distal negative glucocorticoid response element. J Biol Chem 274:2372-2378.
21. Chang MM, Juarez M, Hyde DM, and Wu R (2001) Mechanism of dexamethasone-mediated interleukin-8 gene suppression in cultured airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 280:L107- L115.
22. Chen LC, Zhang Z, Myers AC, and Huang SK (2001) Cutting edge: altered pulmonary eosinophilic inflammation in mice deficient for Clara cell secretory 10-kDa Protein. J Immunol 167:3025-3028.
23. Chen P, Li J, Barnes J, Kokkonen GC, Lee JC, and Liu Y (2002) Restraint of proinflammatory cytokine biosynthesis by mitogen-activated protein kinase phosphatase-1 in lipopolysaccharide-stimulated macrophages. J Immunol 169:6408-6416.
24. Chen S, Sarlis NJ, and Simons SS Jr (2000) Evidence for a common step in three different processes for modulating the kinetic properties of glucocorticoid receptorinduced gene transcription. J Biol Chem 275:30106-30117.
25. Chivers JE, Gong W, King EM, Seybold J, Mak JC, Donnelly LE, Holden NS, and Newton R (2006) Analysis of the dissociated steroid, RU24858, does not exclude a role for inducible genes in the anti-inflammatory actions of glucocorticoids. Mol Pharmacol 70:2084-2095.
26. Cho S, Blackford JA Jr, and Simons SS Jr (2005) Role of activation function domain-1, DNA binding, and coactivator GRIP1 in the expression of partial agonist activity of glucocorticoid receptor-antagonist complexes. Biochemistry 44:3547-3561.
27. Chu Y, Solski PA, Khosravi-Far R, Der CJ, and Kelly K (1996) The mitogen-activated protein kinase phosphatases PAC1, MKP-1, and MKP-2 have unique substrate specificities and reduced activity in vivo toward the ERK2 sevenmaker mutation. J Biol Chem 271:6497-6501.
28. Clark AR (2003) MAP kinase phosphatase 1: a novel mediator of biological effects of glucocorticoids? J Endocrinol 178:5-12.
29. Coghlan MJ, Jacobson PB, Lane B, Nakane M, Lin CW, Elmore SW, Kym PR, Luly JR, Carter GW, Turner R, et al. (2003) A novel antiinflammatory maintains glucocorticoid efficacy with reduced side effects. Mol Endocrinol 17:860-869.
30. Dahlman-Wright K, Wright A, Gustafsson JA, and Carlstedt-Duke J (1991) Interaction of the glucocorticoid receptor DNA-binding domain with DNA as a dimer is mediated by a short segment of five amino acids. J Biol Chem 266:3107-3112.
31. Danesch U, Gloss B, Schmid W, Schutz G, Schüle R, and Renkawitz R (1987) Glucocorticoid induction of the rat tryptophan oxygenase gene is mediated by two widely separated glucocorticoid-responsive elements. EMBO J 6:625-630.
32. De Bosscher K, Schmitz ML, Vanden Berghe W, Plaisance S, Fiers W, and Haegeman G (1997) Glucocorticoid-mediated repression of nuclear factor-kappaB-dependent transcription involves direct interference with transactivation. Proc Natl Acad Sci U S A 94:13504-13509.
33. De Bosscher K, Vanden Berghe W, Beck IM, Van Molle W, Hennuyer N, Hapgood J, Libert C, Staels B, Louw A, and Haegeman G (2005) A fully dissociated compound of plant origin for inflammatory gene repression. Proc Natl Acad Sci U S A 102:15827-15832.
34. De Bosscher K, Vanden Berghe W, and Haegeman G (2001) Glucocorticoid repression of AP-1 is not mediated by competition for nuclear coactivators. Mol Endocrinol 15:219-227.
35. De Bosscher K, Vanden Berghe W, and Haegeman G (2003) The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression. Endocr Rev 24:488-522.
36. De Bosscher K, Vanden Berghe W, Vermeulen L, Plaisance S, Boone E, and Haegeman G (2000) Glucocorticoids repress NF-kappaB-driven genes by disturbing the interaction of P65 with the basal transcription machinery, irrespective of coactivator levels in the cell. Proc Natl Acad Sci U S A 97:3919-3924.
37. Donn R, Berry A, Stevens A, Farrow S, Betts J, Stevens R, Clayton C, Wang J, Warnock L, Worthington J, et al. (2007) Use of gene expression profiling to identify a novel glucocorticoid sensitivity determining gene, BMPRII. FASEB J 21:402-414.
38. Drouin J, Sun YL, and Nemer M (1989a) Glucocorticoid repression of proopiomelanocortin gene transcription. J Steroid Biochem 34:63-69.
39. Drouin J, Trifiro MA, Plante RK, Nemer M, Eriksson P, and Wrange O (1989b) Glucocorticoid receptor binding to a specific DNA sequence is required for hormone-dependent repression of pro-opiomelanocortin gene transcription. Mol Cell Biol 9:5305-5314.
40. Eberhardt W, Kilz T, Akool e, Muller R, and Pfeilschifter J (2005) Dissociated glucocorticoids equipotently inhibit cytokine- and CAMP-induced matrix degrading proteases in rat mesangial cells. Biochem Pharmacol 70:433-445.
41. Eddleston J, Herschbach J, Wagelie-Steffen AL, Christiansen SC, and Zuraw BL (2007) The anti-inflammatory effect of glucocorticoids is mediated by glucocorticoid-induced leucine zipper in epithelial cells. J Allergy Clin Immunol 119:115-122.
42. Elmore SW, Coghlan MJ, Anderson DD, Pratt JK, Green BE, Wang AX, Stashko MA, Lin CW, Tyree CM, Miner JN, et al. (2001) Nonsteroidal selective glucocorticoid modulators: the effect of C-5 alkyl substitution on the transcriptional activation/repression profile of 2,5-dihydro-10-methoxy-2,2,4- trimethyl-1H-[1]benzopyrano[3,4-f]quinolines. J Med Chem 44:4481-4491.
43. Elmore SW, Pratt JK, Coghlan MJ, Mao Y, Green BE, Anderson DD, Stashko MA, Lin CW, Falls D, Nakane M, et al. (2004) Differentiation of in vitro transcriptional repression and activation profiles of selective glucocorticoid modulators. Bioorg Med Chem Lett 14:1721-1727.
44. Fan J, Heller NM, Gorospe M, Atasoy U, and Stellato C (2005) The role of posttranscriptional regulation in chemokine gene expression in inflammation and allergy. Eur Respir J 26:933-947.
45. Flower RJ and Rothwell NJ (1994) Lipocortin-1: cellular mechanisms and clinical relevance. Trends Pharmacol Sci 15:71-76.
46. Franklin CC and Kraft AS (1997) Conditional expression of the mitogen-activated protein kinase (MAPK) phosphatase MKP-1 preferentially inhibits P38 MAPK and stress-activated protein kinase in U937 cells. J Biol Chem 272:16917-16923.
47. Freedman LP (1999) Increasing the complexity of coactivation in nuclear receptor signaling. Cell 97:5-8.
48. Fürst R, Schroeder T, Eilken HM, Bubik MF, Kiemer AK, Zahler S, and Vollmar AM (2007) MAPK phosphatase-1 represents a novel anti-inflammatory target of glucocorticoids in the human endothelium. FASEB J 21:74-80.
49. Galon J, Franchimont D, Hiroi N, Frey G, Boettner A, Ehrhart-Bornstein M, O'Shea JJ, Chrousos GP, and Bornstein SR (2002) Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J 16:61-71.
50. Garside H, Stevens A, Farrow S, Normand C, Houle B, Berry A, Maschera B, and Ray D (2004) Glucocorticoid ligands specify different interactions with NF-kappaB by allosteric effects on the glucocorticoid receptor DNA binding domain. J Biol Chem 279:50050-50059.
51. Godot V, Garcia G, Capel F, Arock M, Durand-Gasselin I, Asselin-Labat ML, Emilie D, and Humbert M (2006) Dexamethasone and IL-10 stimulate glucocorticoidinduced leucine zipper synthesis by human mast cells. Allergy 61:886-890.
52. Gotoh T, Chowdhury S, Takiguchi M, and Mori M (1997) The glucocorticoidresponsive gene cascade. Activation of the rat arginase gene through induction of C/EBPβ. J Biol Chem 272:3694-3698.
53. Graham TE, Prossnitz ER, and Dorin RI (2002) Dexras1/AGS-1 inhibits signal transduction from the Gi-coupled formyl peptide receptor to Erk-1/2 MAP kinases. J Biol Chem 277:10876-10882.
54. Haddad EB, Fox AJ, Rousell J, Burgess G, McIntyre P, Barnes PJ, and Chung KF (2000) Post-transcriptional regulation of bradykinin B1 and B2 receptor gene expression in human lung fibroblasts by tumor necrosis factor-: modulation by dexamethasone. Mol Pharmacol 57:1123-1131.
55. Heck S, Bender K, Kullmann M, Gottlicher M, Herrlich P, and Cato AC (1997) I kappaB alpha-independent downregulation of NF-kappab activity by glucocorticoid receptor. EMBO J 16:4698-4707.
56. Heck S, Kullmann M, Gast A, Ponta H, Rahmsdorf HJ, Herrlich P, and Cato AC (1994) A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP-1. EMBO J 13:4087-4095.
57. Hiragun T, Peng Z, and Beaven MA (2005) Dexamethasone up-regulates the inhibitory adaptor protein dok-1 and suppresses downstream activation of the mitogen-activated protein kinase pathway in antigen-stimulated RBL-2H3 mast cells. Mol Pharmacol 67:598-603.
58. Hiragun T, Peng Z, and Beaven MA (2006) Cutting edge: dexamethasone negatively regulates Syk in mast cells by up-regulating SRC-like adaptor protein. J Immunol 177:2047-2050.
59. Hofmann TG and Schmitz ML (2002) The promoter context determines mutual repression or synergism between NF-B and the glucocorticoid receptor. Biol Chem 383:1947-1951.
60. Humphrey EL, Williams JH, Davie MW, and Marshall MJ (2006) Effects of dissociated glucocorticoids on OPG and RANKL in osteoblastic cells. Bone 38:652-661.
61. Issa R, Xie S, Khorasani N, Sukkar M, Adcock IM, Lee KY, and Chung KF (2007) Corticosteroid inhibition of growth-related oncogene protein-{alpha} via mitogen-activated kinase phosphatase-1 in airway smooth muscle cells. J Immunol 178:7366-7375.
62. Ito K, Barnes PJ, and Adcock IM (2000) Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12. Mol Cell Biol 20:6891-6903.
63. Ito K, Jazrawi E, Cosio B, Barnes PJ, and Adcock IM (2001) P65-activated histone acetyltransferase activity is repressed by glucocorticoids: mifepristone fails to recruit HDAC2 to the P65-HAT complex. J Biol Chem 276:30208-30215.
64. Ito K, Yamamura S, Essilfie-Quaye S, Cosio B, Ito M, Barnes PJ, and Adcock IM (2006) Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression. J Exp Med 203:7-13.
65. Jalonen U, Lahti A, Korhonen R, Kankaanranta H, and Moilanen E (2005) Inhibition of tristetraprolin expression by dexamethasone in activated macrophages. Biochem Pharmacol 69:733-740.
66. Janka-Junttila M, Moilanen E, Hasala H, Zhang X, Adcock I, and Kankaanranta H (2006) The glucocorticoid RU24858 does not distinguish between transrepression and transactivation in primary human eosinophils. J Inflamm (Lond) 3:10.
67. Jantzen HM, Strähle U, Gloss B, Stewart F, Schmid W, Boshart M, Miksicek R, and Schutz G (1987) Cooperativity of glucocorticoid response elements located far upstream of the tyrosine aminotransferase gene. Cell 49:29-38.
68. Jonat C, Rahmsdorf HJ, Park KK, Cato AC, Gebel S, Ponta H, and Herrlich P (1990) Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell 62:1189-1204.
69. Kabotyanski EB, Huetter M, Xian W, Rijnkels M, and Rosen JM (2006) Integration of prolactin and glucocorticoid signaling at the beta-casein promoter and enhancer by ordered recruitment of specific transcription factors and chromatin modifiers. Mol Endocrinol 20:2355-2368.
70. Kamei Y, Xu L, Heinzel T, Torchia J, Kurokawa R, Gloss B, Lin SC, Heyman RA, Rose DW, Glass CK, et al. (1996) A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85:403-414.
71. Kassel O, Sancono A, Kratzschmar J, Kreft B, Stassen M, and Cato AC (2001) Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1. EMBO J 20:7108-7116.
72. Kauppi B, Jakob C, Farnegardh M, Yang J, Ahola H, Alarcon M, Calles K, Engstrom O, Harlan J, Muchmore S, et al. (2003) The three-dimensional structures of antagonistic and agonistic forms of the glucocorticoid receptor ligand-binding domain: RU-486 induces a transconformation that leads to active antagonism. J Biol Chem 278:22748-22754.
73. Kemppainen RJ and Behrend EN (1998) Dexamethasone rapidly induces a novel Ras superfamily member-related gene in Att-20 Cells. J Biol Chem 273:3129-3131.
74. Kern JA, Lamb RJ, Reed JC, Daniele RP, and Nowell PC (1988) Dexamethasone inhibition of interleukin 1 beta production by human monocytes. Posttranscriptional mechanisms. J Clin Invest 81:237-244.
75. Kleinert H, Euchenhofer C, Ihrig-Biedert I, and Forstermann U (1996) Glucocorticoids inhibit the induction of nitric oxide synthase II by down-regulating cytokine-induced activity of transcription factor nuclear factor-B. Mol Pharmacol 49:15-21.
76. König H, Ponta H, Rahmsdorf HJ, and Herrlich P (1992) Interference between pathway-specific transcription factors: glucocorticoids antagonize phorbol esterinduced AP-1 activity without altering AP-1 site occupation in vivo. EMBO J 11:2241-2246.
77. Kordula T and Travis J (1996) The role of Stat and C/EBP transcription factors in the synergistic activation of rat serine protease inhibitor-3 gene by interleukin-6 and dexamethasone. Biochem J 313:1019-1027.
78. Korhonen R, Lahti A, Hamalainen M, Kankaanranta H, and Moilanen E (2002) Dexamethasone inhibits inducible nitric-oxide synthase expression and nitric oxide production by destabilizing mRNA in lipopolysaccharide-treated macrophages. Mol Pharmacol 62:698-704.
79. Kurokouchi K, Kambe F, Kikumori T, Sakai T, Sarkar D, Ishiguro N, Iwata H, and Seo H (2000) Effects of glucocorticoids on tumor necrosis factor alpha-dependent activation of nuclear factor kappaB and expression of the intercellular adhesion molecule 1 gene in osteoblast-like ROS17/2.8 Cells. J Bone Miner Res 15:1707-1715.
80. Lai WS, Carballo E, Strum JR, Kennington EA, Phillips RS, and Blackshear PJ (1999) Evidence that tristetraprolin binds to AU-rich elements and promotes the deadenylation and destabilization of tumor necrosis factor alpha mRNA. Mol Cell Biol 19:4311-4323.
81. Lasa M, Abraham SM, Boucheron C, Saklatvala J, and Clark AR (2002) Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK P38. Mol Cell Biol 22:7802-7811.
82. Lasa M, Brook M, Saklatvala J, and Clark AR (2001) Dexamethasone destabilizes cyclooxygenase 2 mRNA by inhibiting mitogen-activated protein kinase P38. Mol Cell Biol 21:771-780.
83. Lasa M, Mahtani KR, Finch A, Brewer G, Saklatvala J, and Clark AR (2000) Regulation of cyclooxygenase 2 mRNA stability by the mitogen-activated protein kinase P38 signaling cascade. Mol Cell Biol 20:4265-4274.
84. Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, Green D, McNulty D, Blumenthal MJ, Heys JR, Landvatter SW, et al. (1994) Involved in the regulation of inflammatory cytokine biosynthesis. Nature 372:739-746.
85. Lee SW, Tsou AP, Chan H, Thomas J, Petrie K, Eugui EM, and Allison AC (1988) Glucocorticoids selectively inhibit the transcription of the interleukin 1 beta gene and decrease the stability of interleukin 1 beta mRNA. Proc Natl Acad Sci U S A 85:1204-1208.
86. Lerner L, Henriksen MA, Zhang X, and Darnell JE Jr (2003) STAT3-dependent enhanceosome assembly and disassembly: synergy with GR for full transcriptional increase of the alpha 2-macroglobulin gene. Genes Dev 17:2564-2577.
87. Liden J, Delaunay F, Rafter I, Gustafsson J, and Okret S (1997) A new function for the C-terminal zinc finger of the glucocorticoid receptor. Repression of RelA transactivation. J Biol Chem 272:21467-21472.
88. Liu Y, Gorospe M, Yang C, and Holbrook NJ (1995) Role of mitogen-activated protein kinase phosphatase during the cellular response to genotoxic stress. Inhibition of c-Jun N-terminal kinase activity and AP-1-dependent gene activation. J Biol Chem 270:8377-8380.
89. Losel RM, Falkenstein E, Feuring M, Schultz A, Tillmann HC, Rossol-Haseroth K, and Wehling M (2003) Nongenomic steroid action: controversies, questions, and answers. Physiol Rev 83:965-1016.
90. Luecke HF and Yamamoto KR (2005) The glucocorticoid receptor blocks P-TEFb recruitment by NFkappaB to effect promoter-specific transcriptional repression. Genes Dev 19:1116-1127.
91. Martens C, Bilodeau S, Maira M, Gauthier Y, and Drouin J (2005) Protein-protein interactions and transcriptional antagonism between the subfamily of NGFI-B/Nur77 orphan nuclear receptors and glucocorticoid receptor. Mol Endocrinol 19:885-897.
92. McKay LI, and Cidlowski JA (1998) Cross-talk between nuclear factor-kappa B and the steroid hormone receptors: mechanisms of mutual antagonism. Mol Endocrinol 12:45-56.
93. McKay LI, and Cidlowski JA (2000) CBP (CREB binding protein) integrates NFkappaB (nuclear factor-kappaB) and glucocorticoid receptor physical interactions and antagonism. Mol Endocrinol 14:1222-1234.
94. McKenna NJ, and O'Malley BW (2002) Minireview: nuclear receptor coactivators-an update. Endocrinology 143:2461-2465.
95. Meijer OC, Kalkhoven E, van der LS, Steenbergen PJ, Houtman SH, Dijkmans TF, Pearce D, and de Kloet ER (2005) Steroid receptor coactivator-1 splice variants differentially affect corticosteroid receptor signaling. Endocrinology 146:1438-1448.
96. Meyer T, Carlstedt-Duke J, and Starr DB (1997) A weak TATA box is a prerequisite for glucocorticoid-dependent repression of the osteocalcin gene. J Biol Chem 272:30709-30714.
97. Mozo L, Gayo A, Suarez A, Rivas D, Zamorano J, and Gutierrez C (1998) Glucocorticoids inhibit IL-4 and mitogen-induced IL-4R alpha chain expression by different posttranscriptional mechanisms. J Allergy Clin Immunol 102:968-976.
98. Mittelstadt PR and Ashwell JD (2001) Inhibition of AP-1 by the glucocorticoidinducible protein GILZ. J Biol Chem 276:29603-29610.
99. Mukaida N, Morita M, Ishikawa Y, Rice N, Okamoto S, Kasahara T, and Matsushima K (1994) Novel mechanism of glucocorticoid-mediated gene repression. Nuclear factor-κB is target for glucocorticoid-mediated interleukin 8 gene repression. J Biol Chem 269:13289-13295.
100. Mukhopadhyay SS, Wyszomierski SL, Gronostajski RM, and Rosen JM (2001) Differential interactions of specific nuclear factor I isoforms with the glucocorticoid receptor and STAT5 in the cooperative regulation of WAP gene transcription. Mol Cell Biol 21:6859-6869.
101. Mullick J, Anandatheerthavarada HK, Amuthan G, Bhagwat SV, Biswas G, Camasamudram V, Bhat NK, Reddy SE, Rao V, and Avadhani NG (2001) Physical interaction and functional synergy between glucocorticoid receptor and Ets2 proteins for transcription activation of the rat cytochrome P-450C27 Promoter. J Biol Chem 276:18007-18017.
102. Newton R (2000) Molecular mechanisms of glucocorticoid action: what is important? Thorax 55:603-613.
103. Newton R, Hart LA, Stevens DA, Bergmann M, Donnelly LE, Adcock IM, and Barnes PJ (1998a) Effect of dexamethasone on interleukin-1beta-(IL-1beta)- induced nuclear factor-kappab (NF-kappab) and kappab-dependent transcription in epithelial cells. Eur J Biochem 254:81-89.
104. Newton R and Holden N (2003) Inhibitors of P38 mitogen-activated protein kinase: potential as anti-Inflammatory Agents in Asthma? BioDrugs 17:113-129.
105. Newton R, Seybold J, Kuitert LM, Bergmann M, and Barnes PJ (1998b) Repression of cyclooxygenase-2 and prostaglandin E2 release by dexamethasone occurs by transcriptional and post-transcriptional mechanisms involving loss of polyadenylated mRNA. J Biol Chem 273:32312-32321.
106. Nguyen CH and Watts VJ (2006) Dexamethasone-induced ras protein 1 negatively regulates protein kinase c delta: implications for adenylyl cyclase 2 signaling. Mol Pharmacol 69:1763-1771.
107. Nissen RM and Yamamoto KR (2000) The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxyterminal domain. Genes Dev 14:2314-2329.
108. Ohtsuka T, Kubota A, Hirano T, Watanabe K, Yoshida H, Tsurufuji M, Iizuka Y, Konishi K, and Tsurufuji S (1996) Glucocorticoid-mediated gene suppression of rat cytokine-induced neutrophil chemoattractant CINC/Gro, a member of the interleukin-8 family, through impairment of NF-kappa B activation. J Biol Chem 271:1651-1659.
109. Pearce D, Matsui W, Miner JN, and Yamamoto KR (1998) Glucocorticoid receptor transcriptional activity determined by spacing of receptor and nonreceptor DNA sites. J Biol Chem 273:30081-30085.
110. Pearce D and Yamamoto KR (1993) Mineralocorticoid and glucocorticoid receptor activities distinguished by nonreceptor factors at a composite response element. Science 259:1161-1165.
111. Peppel K, Vinci JM, and Baglioni C (1991) The AU-rich sequences in the 3′ untranslated region mediate the increased turnover of interferon mRNA induced by glucocorticoids. J Exp Med 173:349-355.
112. Planey SL, Abrams MT, Robertson NM, and Litwack G (2003) Role of apical caspases and glucocorticoid-regulated genes in glucocorticoid-induced apoptosis of pre-B leukemic cells. Cancer Res 63:172-178.
113. Poon M, Liu B, and Taubman MB (1999) Identification of a novel dexamethasone-sensitive RNA-destabilizing region on rat monocyte chemoattractant protein 1 mRNA. Mol Cell Biol 19:6471-6478.
114. Pratt WB, Galigniana MD, Harrell JM, and DeFranco DB (2004) Role of Hsp90 and the Hsp90-binding immunophilins in signalling protein movement. Cell Signal 16:857-872.
115. Ray A and Prefontaine KE (1994) Physical association and functional antagonism between the P65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor. Proc Natl Acad Sci U S A 91:752-756.
116. Ray KP, Farrow S, Daly M, Talabot F, and Searle N (1997) Induction of the E-selectin promoter by interleukin 1 and tumour necrosis factor alpha, and inhibition by glucocorticoids. Biochem J 328:707-715.
117. Re F, Muzio M, De Rossi M, Polentarutti N, Giri JG, Mantovani A, and Colotta F (1994) The type II "receptor" as a decoy target for interleukin 1 in polymorphonuclear leukocytes: characterization of induction by dexamethasone and ligand binding properties of the released decoy receptor. J Exp Med 179:739-743.
118. Reichardt HM, Kaestner KH, Tuckermann J, Kretz O, Wessely O, Bock R, Gass P, Schmid W, Herrlich P, Angel P, et al. (1998) DNA binding of the glucocorticoid receptor is not essential for survival. Cell 93:531-541.
119. Reichardt HM, Tuckermann JP, Gottlicher M, Vujic M, Weih F, Angel P, Herrlich P, and Schutz G (2001) Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor. EMBO J 20:7168-7173.
120. Reisman D and Thompson EA (1995) Glucocorticoid regulation of cyclin D3 gene transcription and mRNA stability in lymphoid cells. Mol Endocrinol 9:1500-1509.
121. Rhen T and Cidlowski JA (2005) Antiinflammatory action of glucocorticoids-new mechanisms for old drugs. N Engl J Med 353:1711-1723.
122. Ristimaki A, Narko K, and Hla T (1996) Down-regulation of cytokine-induced cyclooxygenase-2 transcript isoforms by dexamethasone: evidence for post-transcriptional regulation. Biochem J 318:325-331.
123. Rogatsky I, Luecke HF, Leitman DC, and Yamamoto KR (2002) Alternate surfaces of transcriptional coregulator GRIP1 function in different glucocorticoid receptor activation and repression contexts. Proc Natl Acad Sci U S A 99:16701-16706.
124. Rogatsky I, Wang JC, Derynck MK, Nonaka DF, Khodabakhsh DB, Ha CM, Darimont BD, Garabedian MJ, and Yamamoto KR (2003) Target-specific utilization of transcriptional regulatory surfaces by the glucocorticoid receptor. Proc Natl Acad Sci U S A 100:13845-13850.
125. Rogatsky I, Zarember KA, and Yamamoto KR (2001) Factor recruitment and TIF2/GRIP1 corepressor activity at a collagenase-3 response element that mediates regulation by phorbol esters and hormones. EMBO J 20:6071-6083.
126. Sakai DD, Helms S, Carlstedt-Duke J, Gustafsson JA, Rottman FM, and Yamamoto KR (1988) Hormone-mediated repression: a negative glucocorticoid response element from the bovine prolactin gene. Genes Dev 2:1144-1154.
127. Schäcke H, Docke WD, and Asadullah K (2002) Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther 96:23-43.
128. Schäcke H, Schottelius A, Docke WD, Strehlke P, Jaroch S, Schmees N, Rehwinkel H, Hennekes H, and Asadullah K (2004) Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects. Proc Natl Acad Sci U S A 101:227-232.
129. Scheinman RI, Cogswell PC, Lofquist AK, and Baldwin AS Jr (1995a) Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science 270:283-286.
130. Scheinman RI, Gualberto A, Jewell CM, Cidlowski JA, and Baldwin AS Jr (1995b) Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors. Mol Cell Biol 15:943-953.
131. Schüle R, Muller M, Kaltschmidt C, and Renkawitz R (1988) Many transcription factors interact synergistically with steroid receptors. Science 242:1418-1420.
132. Schüle R, Rangarajan P, Kliewer S, Ransone LJ, Bolado J, Yang N, Verma IM, and Evans RM (1990) Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell 62:1217-1226.
133. Shah N and Scanlan TS (2004) Design and evaluation of novel nonsteroidal dissociating glucocorticoid receptor ligands. Bioorg Med Chem Lett 14:5199-5203.
134. Sheppard KA, Phelps KM, Williams AJ, Thanos D, Glass CK, Rosenfeld MG, Gerritsen ME, and Collins T (1998) Nuclear integration of glucocorticoid receptor and nuclear factor-kappaB signaling by CREB-binding protein and steroid receptor coactivator-1. J Biol Chem 273:29291-29294.
135. Simpson CS and Morris BJ (1999) Activation of nuclear factor kappaB by nitric oxide in rat striatal neurones: differential inhibition of the P50 and P65 subunits by dexamethasone. J Neurochem 73:353-361.
136. Slack DN, Seternes OM, Gabrielsen M, and Keyse SM (2001) Distinct binding determinants for ERK2/P38α and JNK Map kinases mediate catalytic activation and substrate selectivity of Map kinase phosphatase-1. J Biol Chem 276:16491-16500.
137. Smoak K and Cidlowski JA (2006) Glucocorticoids regulate tristetraprolin synthesis and posttranscriptionally regulate tumor necrosis factor alpha inflammatory signaling. Mol Cell Biol 26:9126-9135.
138. So AY, Chaivorapol C, Bolton EC, Li H, and Yamamoto KR (2007) Determinants of cell- and gene-specific transcriptional regulation by the glucocorticoid receptor. PLoS Genet 3:e94.
139. Staples KJ, Bergmann MW, Barnes PJ, and Newton R (2003) Evidence for posttranscriptional regulation of interleukin-5 by dexamethasone. Immunology 109:527-535.
140. Stellato C (2004) Post-transcriptional and nongenomic effects of glucocorticoids. Proc Am Thorac Soc 1:255-263.
141. Stöcklin E, Wissler M, Gouilleux F, and Groner B (1996) Functional interactions between stat5 and the glucocorticoid receptor. Nature 383:726-728.
142. Strähle U, Schmid W, and Schutz G (1988) Synergistic action of the glucocorticoid receptor with transcription factors. EMBO J 7:3389-3395.
143. Strömstedt PE, Poellinger L, Gustafsson JA, and Carlstedt-Duke J (1991) The glucocorticoid receptor binds to a sequence overlapping the TATA box of the human osteocalcin promoter: a potential mechanism for negative regulation. Mol Cell Biol 11:3379-3383.
144. Subramaniam N, Cairns W, and Okret S (1998) Glucocorticoids repress transcription from a negative glucocorticoid response element recognized by two homeodomaincontaining proteins, Pbx and Oct-1. J Biol Chem 273:23567-23574.
145. Swantek JL, Cobb MH, and Geppert TD (1997) Jun N-terminal
146. Tai TC, Claycomb R, Her S, Bloom AK, and Wong DL (2002) Glucocorticoid responsiveness of the rat phenylethanolamine N-methyltransferase gene. Mol Pharmacol 61:1385-1392.
147. Takeda T, Kurachi H, Yamamoto T, Nishio Y, Nakatsuji Y, Morishige K, Miyake A, and Murata Y (1998) Crosstalk between the interleukin-6 (IL-6)-JAK-STAT and the glucocorticoid-nuclear receptor pathway: synergistic activation of IL-6 response element by IL-6 and glucocorticoid. J Endocrinol 159:323-330.
148. Tanigawa K, Tanaka K, Nagase H, Miyake H, Kiniwa M, and Ikizawa K (2002) Cell type-dependent divergence of transactivation by glucocorticoid receptor ligand. Biol Pharm Bull 25:1619-1622.
149. Tao Y, Williams-Skipp C, and Scheinman RI (2001) Mapping of glucocorticoid receptor DNA binding domain surfaces contributing to transrepression of NF-κB and induction of apoptosis. J Biol Chem 276:2329-2332.
150. Teurich S and Angel P (1995) The glucocorticoid receptor synergizes with Jun homodimers to activate AP-1-regulated promoters lacking GR binding sites. Chem Senses 20:251-255.
151. Tobler A, Meier R, Seitz M, Dewald B, Baggiolini M, and Fey MF (1992) Glucocorticoids downregulate gene expression of GM-CSF, NAP-1/IL-8, and IL-6, but not of M-CSF in human fibroblasts. Blood 79:45-51.
152. Tronche F, Opherk C, Moriggl R, Kellendonk C, Reimann A, Schwake L, Reichardt HM, Stangl K, Gau D, Hoeflich A, et al. (2004) Glucocorticoid receptor function in hepatocytes is essential to promote postnatal body growth. Genes Dev 18:492-497.
153. Tuckermann JP, Reichardt HM, Arribas R, Richter KH, Schutz G, and Angel P (1999) The DNA binding-independent function of the glucocorticoid receptor mediates repression of AP-1-dependent genes in skin. J Cell Biol 147:1365-1370.
154. Uings IJ and Farrow SN (2005) A pharmacological approach to enhancing the therapeutic index of corticosteroids in airway inflammatory disease. Curr Opin Pharmacol 5:221-226.
155. van de Stolpe A, Caldenhoven E, Stade BG, Koenderman L, Raaijmakers JA, Johnson JP, and van der Saag PT (1994) 12-O-Tetradecanoylphorbol-13- acetate- and tumor necrosis factor α-mediated induction of intercellular adhesion molecule-1 is inhibited by dexamethasone. Functional analysis of the human intercellular adhesion molecular-1 promoter. J Biol Chem 269:6185-6192.
156. Vanden Berghe W, Francesconi E, De Bosscher K, Resche-Rigon M, and Haegeman G (1999) Dissociated glucocorticoids with anti-inflammatory potential repress interleukin-6 gene expression by a nuclear factor-κB-dependent mechanism. Mol Pharmacol 56:797-806.
157. Vayssière BM, Dupont S, Choquart A, Petit F, Garcia T, Marchandeau C, Gronemeyer H, and Resche-Rigon M (1997) Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo. Mol Endocrinol 11:1245-1255.
158. Wang J, Zhu Z, Nolfo R, and Elias JA (1999) Dexamethasone regulation of lung epithelial cell and fibroblast interleukin-11 production. Am J Physiol 276:L175-L185.
159. Wang JC, Shah N, Pantoja C, Meijsing SH, Ho JD, Scanlan TS, and Yamamoto KR (2006a) Novel arylpyrazole compounds selectively modulate glucocorticoid receptor regulatory activity. Genes Dev 20:689-699.
160. Wang Q, Blackford JA Jr, Song LN, Huang Y, Cho S, and Simons SS Jr (2004) Equilibrium interactions of corepressors and coactivators with agonist and antagonist complexes of glucocorticoid receptors. Mol Endocrinol 18:1376-1395.
161. Wang Y, Zhang JJ, Dai W, Lei KY, and Pike JW (1997) Dexamethasone potently enhances phorbol ester-induced IL-1beta gene expression and nuclear factor NF-kappaB activation. J Immunol 159:534-537.
162. Wang Z, Malone MH, He H, McColl KS, and Distelhorst CW (2003) Microarray analysis uncovers the induction of the proapoptotic BH3-only protein Bim in multiple models of glucocorticoid-induced apoptosis. J Biol Chem 278:23861-23867.
163. Wang Z, Rong YP, Malone MH, Davis MC, Zhong F, and Distelhorst CW (2006b) Thioredoxin-interacting protein (Txnip) is a glucocorticoid-regulated primary response gene involved in mediating glucocorticoid-induced apoptosis. Oncogene 25:1903-1913.
164. Webster JC, Huber RM, Hanson RL, Collier PM, Haws TF, Mills JK, Burn TC, and Allegretto EA (2002) Dexamethasone and tumor necrosis factor-alpha act together to induce the cellular inhibitor of apoptosis-2 gene and prevent apoptosis in a variety of cell types. Endocrinology 143:3866-3874.
165. Wesselborg S, Bauer MK, Vogt M, Schmitz ML, and Schulze-Osthoff K (1997) Activation of transcription factor NF-κB and P38 mitogen-activated protein kinase is mediated by distinct and separate stress effector pathways. J Biol Chem 272:12422-12429.
166. Winzen R, Kracht M, Ritter B, Wilhelm A, Chen CY, Shyu AB, Muller M, Gaestel M, Resch K, and Holtmann H (1999) The P38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism. EMBO J 18:4969-4980.
167. Wissink S, van Heerde EC, vand der BB, and van der Saag PT (1998) A dual mechanism mediates repression of NF-kappaB activity by glucocorticoids. Mol Endocrinol 12:355-363.
168. Wu J, Li Y, Dietz J, and Lala DS (2004) Repression of P65 transcriptional activation by the glucocorticoid receptor in the absence of receptor-coactivator interactions. Mol Endocrinol 18:53-62.
169. Wu JJ, Zhang L, and Bennett AM (2005) The noncatalytic amino terminus of mitogen-activated protein kinase phosphatase 1 directs nuclear targeting and serum response element transcriptional regulation. Mol Cell Biol 25:4792-4803.
170. Wyszomierski SL and Rosen JM (2001) Cooperative effects of STAT5 (signal transducer and activator of transcription 5) and C/EBPbeta (CCAAT/enhancer- binding protein-beta) on beta-casein gene transcription are mediated by the glucocorticoid receptor. Mol Endocrinol 15:228-240.
171. Xu M, Modarress KJ, Meeker JE, and Simons SS Jr (1999) Steroid-induced conformational changes of rat glucocorticoid receptor cause altered trypsin cleavage of the putative helix 6 in the ligand binding domain. Mol Cell Endocrinol 155:85-100.
172. Yang-Yen HF, Chambard JC, Sun YL, Smeal T, Schmidt TJ, Drouin J, and Karin M (1990) Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 62:1205-1215.
173. Yao XL, Cowan MJ, Gladwin MT, Lawrence MM, Angus CW, and Shelhamer JH (1999) Dexamethasone alters arachidonate release from human epithelial cells by induction of P11 protein synthesis and inhibition of phospholipase A2 activity. J Biol Chem 274:17202-17208.
174. Young JD, Lawrence AJ, MacLean AG, Leung BP, McInnes IB, Canas B, Pappin DJ, and Stevenson RD (1999) Thymosin beta 4 sulfoxide is an anti-inflammatory agent generated by monocytes in the presence of glucocorticoids. Nat Med 5:1424-1427.
175. Zhao Q, Shepherd EG, Manson ME, Nelin LD, Sorokin A, and Liu Y (2005) The role of mitogen-activated protein kinase phosphatase-1 in the response of alveolar macrophages to lipopolysaccharide: attenuation of proinflammatory cytokine biosynthesis via feedback control of P38. J Biol Chem 280:8101-8108.